Sanofi and Regeneron announce FDA approval of kevzara® (sarilumab) for the treatment of moderately to severely active rheumatoid arthritis in adult patients

23rd May 2017 Uncategorised 0

Sanofi

More: Sanofi and Regeneron announce FDA approval of kevzara® (sarilumab) for the treatment of moderately to severely active rheumatoid arthritis in adult patients
Source: MDlinx